Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1982;13(Suppl 2):309S–312S. doi: 10.1111/j.1365-2125.1982.tb01932.x

The effect of pindolol on myocardial blood flow, metabolism and function during rest and pacing in patients with coronary heart disease.

W Kupper, C W Hamm, W Bleifeld
PMCID: PMC1402158  PMID: 7104152

Abstract

1 The study was designed to elucidate further the mechanism by which beta-adrenoceptor antagonism with pindolol relieves the symptoms of angina pectoris in patients with coronary heart disease. 2 Pindolol administration was associated with an elevated threshold for angina pectoris and improved myocardial lactate metabolism during supraventricular pacing. 3 This beneficial effect of pindolol was independent of changes in myocardial blood flow and was not mediated by haemodynamic effects. 4 The results suggest that in angina pectoris, in addition to the recognized beneficial effects of beta-adrenoceptor blockade, the actions of pindolol also result from, as yet, poorly described phenomena such as redistribution of myocardial blood flow or metabolic effects.

Full text

PDF
309S

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Armstrong P. W., Chiong M. A., Parker J. O. Effects of propranolol on the hemodynamic, coronary sinus blood flow and myocardial metabolic response to atrial pacing. Am J Cardiol. 1977 Jul;40(1):83–89. doi: 10.1016/0002-9149(77)90105-9. [DOI] [PubMed] [Google Scholar]
  2. Baber N. S., Evans D. W., Howitt G., Thomas M., Wilson T., Lewis J. A., Dawes P. M., Handler K., Tuson R. Multicentre post-infarction trial of propranolol in 49 hospitals in the United Kingdom, Italy, and Yugoslavia. Br Heart J. 1980 Jul;44(1):96–100. doi: 10.1136/hrt.44.1.96. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Battock D. J., Alvarez H., Chidsey C. A. Effects of propranolol and isosorbide dinitrate on exercise performance and adrenergic acitivity in patients with angina pectoris. Circulation. 1969 Feb;39(2):157–169. doi: 10.1161/01.cir.39.2.157. [DOI] [PubMed] [Google Scholar]
  4. Ganz W., Tamura K., Marcus H. S., Donoso R., Yoshida S., Swan H. J. Measurement of coronary sinus blood flow by continuous thermodilution in man. Circulation. 1971 Aug;44(2):181–195. doi: 10.1161/01.cir.44.2.181. [DOI] [PubMed] [Google Scholar]
  5. Gianelly R. E., Goldman R. H., Treister B., Harrison D. C. Propranolol in patients with angina pectoris. Ann Intern Med. 1967 Dec;67(6):1216–1225. doi: 10.7326/0003-4819-67-6-1216. [DOI] [PubMed] [Google Scholar]
  6. Grant R. H., Keelan P., Kernohan R. J., Leonard J. C., Nancekievill L., Sinclair K. Multicenter trial of propranolol in angina pectoris. Am J Cardiol. 1966 Sep;18(3):361–365. doi: 10.1016/0002-9149(66)90054-3. [DOI] [PubMed] [Google Scholar]
  7. Hübner H., Stephan K., Meesmann W., Abendroth R. R. Akuter Myokardinfarkt und Pindolol. Wirkung eines beta-Sympathikolytikums mit intrinsic sympathomimetic activity auf Hämodynamik und Kontraktilität. Arzneimittelforschung. 1976;26(8):1561–1565. [PubMed] [Google Scholar]
  8. Jackson G., Atkinson L., Oram S. Improvement of myocardial metabolism in coronary arterial disease by beta-blockade. Br Heart J. 1977 Aug;39(8):829–833. doi: 10.1136/hrt.39.8.829. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Kirby W. M., De Maine J. B., Serrill W. S. Pharmacokinetics of the cephalosporins in healthy volunteers and uremic patients. Postgrad Med J. 1971 Feb;47(Suppl):41–46. [PubMed] [Google Scholar]
  10. Maroko P. R., Kjekshus J. K., Sobel B. E., Watanabe T., Covell J. W., Ross J., Jr, Braunwald E. Factors influencing infarct size following experimental coronary artery occlusions. Circulation. 1971 Jan;43(1):67–82. doi: 10.1161/01.cir.43.1.67. [DOI] [PubMed] [Google Scholar]
  11. Most A. S., Gorlin R., Soeldner J. S. Glucose extraction by the human myocardium during pacing stress. Circulation. 1972 Jan;45(1):92–96. doi: 10.1161/01.cir.45.1.92. [DOI] [PubMed] [Google Scholar]
  12. Mueller H. S., Ayres S. M., Religa A., Evans R. G. Propranolol in the treatment of acute myocardial infarction. Effect on myocardial oxygenation and hemodynamics. Circulation. 1974 Jun;49(6):1078–1087. doi: 10.1161/01.cir.49.6.1078. [DOI] [PubMed] [Google Scholar]
  13. Pitt B., Craven P. Effect of propranolol on regional myocardial blood flow in acute ischaemia. Cardiovasc Res. 1970 Apr;4(2):176–179. doi: 10.1093/cvr/4.2.176. [DOI] [PubMed] [Google Scholar]
  14. Stephens J., Hayward R., Ead H., Adams L., Hamer J., Spurrell R. Effects of selective and non-selective beta-adrenergic blockade on coronary dynamics in man assessed by rapid atrial pacing. Br Heart J. 1978 Aug;40(8):856–863. doi: 10.1136/hrt.40.8.856. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Thompson D. S., Naqvi N., Juul S. M., Coltart D. J., Jenkins B. S., Webb-Peploe M. M. Haemodynamic and metabolic effects of atenolol in patients with angina pectoris. Br Heart J. 1980 Jun;43(6):668–679. doi: 10.1136/hrt.43.6.668. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Vatner S. F., Baig H., Manders W. T., Ochs H., Pagani M. Effects of propranolol on regional myocardial function, electrograms, and blood flow in conscious dogs with myocardial ischemia. J Clin Invest. 1977 Aug;60(2):353–360. doi: 10.1172/JCI108783. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Wolfson S., Gorlin R. Cardiovascular pharmacology of propranolol in man. Circulation. 1969 Oct;40(4):501–511. doi: 10.1161/01.cir.40.4.501. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES